The assessment of survival outcomes also highlights the negative impact of early progression on OS in the rituximab-era.doi:10.1016/j.clml.2018.12.017Vicki A. MorrisonYaping ShouJill A. BellLaurie HamiltonAaron GalaznikClinical lymphoma, myeloma & leukemia...
Content on this site has been developed by Robert G. Miller, a “retired” college dean and a follicular lymphoma survivor diagnosed over 36 years ago, currently in excellent health, no longer with evidence of lymphoma, confirmed by scan. I started the LymphomaSurvival website with commencement ...
(1996) Prolonged survival in follicular non Hodgkins lymphoma is predicted by achievement of complete remission with initial treatment: results of a long-... M Davidge-Pitts,R Dansey,WR Bezwoda - 《Leukemia & Lymphoma》 被引量: 0发表: 1996年 Prolonged survival in follicular non Hodgkins lymphom...
We assessed stage-specific trends in primary therapy and relative survival among adult follicular lymphoma (FL) patients diagnosed in the Netherlands between 1989–2016 (N = 12,372; median age, 62 years; and 21% stage I disease). Patients were stratified by disease stage and subsequently ...
Follicular lymphoma (FL) is a low-grade B-cell malignancy that transforms into a highly aggressive and lethal disease at a rate of 2% per year. Perfect isolation of the malignant B-cell population from a surgical biopsy is a significant challenge, masking important FL biology, such as immune...
摘要: Objectives: To evaluate the overall survival benefit associated with follicular lymphoma (FL)-directed therapy among patients diagnosed with FL at 80+ years.关键词: Follicular lymphoma Geriatric oncology Survival analysis Cancer treatment
A multivariate Cox model that included the IPI score, the histologic grade, and the lymphoma-associated macrophage (LAM) score, showed IPI and LAM to be independent predictors of OS (P = .009 and P = .004, respectively). The LAM content of FL predicts survival, and these data support a...
Follicular lymphoma (FL) is a lymphoproliferative neoplasia typically considered incurable. It is most often characterized by a slow, indolent disease course with a long-estimated survival period that may span decades [1,2]. However, even with new therapies, progressive disease events are associated...
The presence of these BCL2 mutations at diagnosis correlated with an increased risk of transformation (hazard ratio 3.6; 95% CI, 2.0-6.2; P < .0001) and increased risk of death due to lymphoma (median survival of 9.5 years with BCL2 mutations vs 20.4 years without; P = .012). In a...
among those with shorter survival. Fig. 8: Hypothetical model of FL genesis. MB memory B-cell, GCB germinal center B-cell, MC metacluster, NOS not otherwise specified, Tfh follicular helper T-cell, FLLC follicular lymphoma-like cell.